<div><div><p><b>New Drug Submission</b>: Enter the NDS number listed on the NOC that was issued with respect to the medicinal ingredient or combination of medicinal ingredients; the NOC must meet the requirements set out in subsections 106(1)(c) and (d) of the Patent Act. According to subsection 106(1)(d) of the Patent Act, the NOC must be the first authorization for sale that has been issued in Canada with respect to the medicinal ingredient or the combination of medicinal ingredients, as the case may be. According to subsection 106(1)(c) of the Patent Act, the NOC issuance date must be on or after the day on which that section comes into force, namely June 15, 2017.</p></div></div>